Spots Global Cancer Trial Database for newly diagnosed glioblastoma

Every month we try and update this database with for newly diagnosed glioblastoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)	NCT05163080	Newly Diagnosed...	SurVaxM	18 Years -	MimiVax, LLC
SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)	NCT05163080	Newly Diagnosed...	SurVaxM	18 Years -	MimiVax, LLC
A Dose Escalation Study to Estimate MTD, DLTs and Pharmacokinetics After a Single Intracranial Dose of SI-053 as an add-on to the Current Standard of Care, in Adult Patients With Newly Diagnosed GBM	NCT04967690	Newly Diagnosed...	SI-053	18 Years - 70 Years	Double Bond Pharmaceutical AB
Dose-escalation Study to Evaluate the Safety and Tolerability of GX-I7 in Patients With Glioblastoma	NCT03619239	Newly Diagnosed...	GX-I7	19 Years -	Genexine, Inc.
Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated Glioblastoma	NCT01044225	Glioblastoma	Cetuximab Cilengitide EMD...	18 Years -	Universitair Ziekenhuis Brussel
Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma	NCT02010606	Glioblastoma Glioblastoma Mu... Glioma Astrocytoma Brain Tumor	Dendritic cell ... Dendritic cell ...	18 Years -	Cedars-Sinai Medical Center
A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT)	NCT04600817	Newly Diagnosed...	TJ107 TJ107 placebo	18 Years - 70 Years	TJ Biopharma Co., Ltd.
GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients	NCT02149225	Glioblastoma	APVAC1 vaccine ... APVAC2 vaccine ...	18 Years -	Immatics Biotechnologies GmbH
Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma	NCT02010606	Glioblastoma Glioblastoma Mu... Glioma Astrocytoma Brain Tumor	Dendritic cell ... Dendritic cell ...	18 Years -	Cedars-Sinai Medical Center
A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors	NCT04478279	Glioblastoma Melanoma Stage ... Breast Cancer Prostate Cancer Glioblastoma Mu... GBM Brain Cancer Metastatic Brea... Metastatic Mela... Metastatic Pros... Melanoma Recurr... Prostate Cancer... Recurrent Gliob... Newly Diagnosed...	ST101 Temozolomide Radiation	18 Years -	Sapience Therapeutics
Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma	NCT05864534	Newly Diagnosed... Glioblastoma, I... Gliosarcoma Glioblastoma Mu...	Balstilimab Botensilimab Liposomal Doxor... Sonocloud-9 (SC...	18 Years -	Northwestern University
A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT)	NCT04600817	Newly Diagnosed...	TJ107 TJ107 placebo	18 Years - 70 Years	TJ Biopharma Co., Ltd.
Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas)	NCT02772094	Glioblastoma Mu... Glioblastoma	Single arm, ope...	13 Years - 70 Years	China Medical University Hospital
Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma	NCT05380349	Newly Diagnosed...	combinations of...	18 Years -	Swedish Medical Center
Radiotherapy Planning Using Fluciclovine PET in Patients With Newly Diagnosed Glioblastoma	NCT04840069	Newly Diagnosed...	Fluciclovine PE...	18 Years -	St. Joseph's Hospital and Medical Center, Phoenix
NovoTTF Treatment Signatures in Glioblastoma Patients at Autopsy	NCT03194971	Glioblastoma	Tumor samples f... Tumor samples f...	18 Years -	Medical College of Wisconsin
Clinical Trial to Assess the Efficacy and Safety of 'INNOCELL Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea	NCT00807027	Glioblastoma	Activated T lym...	18 Years - 70 Years	GC Cell Corporation
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer	NCT00045968	Glioblastoma Mu... Glioblastoma GBM Grade IV Astroc... Glioma Brain Cancer Brain Tumor	Dendritic cell ...	18 Years - 70 Years	Northwest Biotherapeutics
Pembrolizumab for Newly Diagnosed Glioblastoma	NCT03899857	Newly Diagnosed...	Pembrolizumab	18 Years -	University of Zurich
GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients	NCT02149225	Glioblastoma	APVAC1 vaccine ... APVAC2 vaccine ...	18 Years -	Immatics Biotechnologies GmbH
The Assessment of Immune Response in Newly Diagnosed Glioblastoma Patients Treated With Pembrolizumab	NCT05235737	Newly Diagnosed...	Pembrolizumab Pembrolizumab	18 Years - 70 Years	Medical University of Silesia
Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma	NCT02364206	Adult Glioblast...	LY2228820 Temozolomide radiotherapy	18 Years - 75 Years	Centre Jean Perrin
Dose-escalation Study to Evaluate the Safety and Tolerability of GX-I7 in Patients With Glioblastoma	NCT03619239	Newly Diagnosed...	GX-I7	19 Years -	Genexine, Inc.
Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma	NCT03782415	Glioblastoma Recurrent Gliob... GBM Newly Diagnosed...	MN-166 Temozolomide	18 Years -	MediciNova
NovoTTF Treatment Signatures in Glioblastoma Patients at Autopsy	NCT03194971	Glioblastoma	Tumor samples f... Tumor samples f...	18 Years -	Medical College of Wisconsin
Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated Glioblastoma	NCT01044225	Glioblastoma	Cetuximab Cilengitide EMD...	18 Years -	Universitair Ziekenhuis Brussel
Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma	NCT04477200	Recurrent Gliob... Recurrent Glios... Recurrent Astro... Newly Diagnosed... Newly Diagnosed... Newly Diagnosed...	Mycophenolate M... Radiation Thera... Re-resection (a... Temozolomide Mycophenolate M... Mycophenolate M... Radiation Thera...	18 Years -	University of Michigan Rogel Cancer Center
Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma	NCT05380349	Newly Diagnosed...	combinations of...	18 Years -	Swedish Medical Center
A Dose Escalation Study to Estimate MTD, DLTs and Pharmacokinetics After a Single Intracranial Dose of SI-053 as an add-on to the Current Standard of Care, in Adult Patients With Newly Diagnosed GBM	NCT04967690	Newly Diagnosed...	SI-053	18 Years - 70 Years	Double Bond Pharmaceutical AB
Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma	NCT04474353	Glioblastoma Newly Diagnosed...	Optune Gadolinium Temozolomide Stereotactic ra...	18 Years -	Stanford University

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: